Krystal Biotech Inc. (KRYS)
NASDAQ · Healthcare
Krystal Biotech Inc. Shareholder Equity 2020–2025
Krystal Biotech Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Krystal Biotech Inc. shareholder equity as of December 31, 2025: 1.22B, a 28.87% increase year-over-year.
- Krystal Biotech Inc. shareholder equity for 2025 were 1.22B, a 28.87% increase from 2024.
- Krystal Biotech Inc. shareholder equity for 2024 were 946.4M, a 21.54% increase from 2023.
- Krystal Biotech Inc. shareholder equity for 2023 were 778.6M, a 49.10% increase from 2022.
- Krystal Biotech Inc. shareholder equity for 2022 were 522.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Krystal Biotech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,220 |
| 2024 | $946 |
| 2023 | $779 |
| 2022 | $522 |
| 2021 | $594 |
| 2020 | $292 |
Krystal Biotech Inc. Shareholder Equity — FAQ
Krystal Biotech Inc. (KRYS) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KRYS's shareholder equity history?
The chart and table above show Krystal Biotech Inc.'s shareholder equity by year and by quarter, including the growth rate.